- Home
- ORBS vs ALGS Comparison
ORBS vs ALGS Comparison
Compare ORBS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORBS
- ALGS
- Stock Information
- Founded
- ORBS 1966
- ALGS 2018
- Country
- ORBS United States
- ALGS United States
- Employees
- ORBS N/A
- ALGS N/A
- Industry
- ORBS
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- ORBS
- ALGS Health Care
- Exchange
- ORBS Nasdaq
- ALGS Nasdaq
- Market Cap
- ORBS 47.6M
- ALGS 53.0M
- IPO Year
- ORBS N/A
- ALGS 2020
- Fundamental
- Price
- ORBS N/A
- ALGS $9.37
- Analyst Decision
- ORBS
- ALGS Strong Buy
- Analyst Count
- ORBS 0
- ALGS 2
- Target Price
- ORBS N/A
- ALGS $60.00
- AVG Volume (30 Days)
- ORBS 12.1M
- ALGS 73.3K
- Earning Date
- ORBS 11-19-2025
- ALGS 11-05-2025
- Dividend Yield
- ORBS N/A
- ALGS N/A
- EPS Growth
- ORBS N/A
- ALGS N/A
- EPS
- ORBS N/A
- ALGS N/A
- Revenue
- ORBS $43,871,615.00
- ALGS $3,174,000.00
- Revenue This Year
- ORBS N/A
- ALGS N/A
- Revenue Next Year
- ORBS N/A
- ALGS $28.79
- P/E Ratio
- ORBS N/A
- ALGS N/A
- Revenue Growth
- ORBS N/A
- ALGS N/A
- 52 Week Low
- ORBS $0.98
- ALGS $3.76
- 52 Week High
- ORBS $83.12
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- ORBS N/A
- ALGS 44.31
- Support Level
- ORBS N/A
- ALGS $10.66
- Resistance Level
- ORBS N/A
- ALGS $11.65
- Average True Range (ATR)
- ORBS 0.00
- ALGS 0.85
- MACD
- ORBS 0.00
- ALGS -0.18
- Stochastic Oscillator
- ORBS 0.00
- ALGS 3.72
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.